摘要
临床药师参与1例蛛网膜下腔出血患者急性心肌梗死的诊疗实践过程,探讨在高出血及高栓塞风险共存情况下的药学监护模式,权衡药物治疗与疾病进展等相关问题,结合循证医学资料,协助医生制定个体化给药方案,为高出血风险急性心肌梗死患者的抗栓治疗结局发挥重要作用。
Clinical pharmacist participated in the diagnosis and practice of acute myocardial infarction in a patient with subarachnoid hemorrhage to explore the pharmaceutical care mode for hospitalized cases with high risks of bleeding and embolism and weigh the related problems between drug treatment and disease progression.Based on evidence-based data,clinical pharmacists assisted physicians in developing individualized drug administration plans.Clinical pharmacists play an important role in the outcome of antithrombotic therapy for patients with acute myocardial infarction and high bleeding risks.
作者
王欣
郑萍
Wang Xin;Zheng Ping(Department of Pharmacy,Xianyang Central Hospital,Shaanxi Xianyang 712000,China;Department of Pharmacy,Nanfang Hospital Affiliated to Southern Medical University)
出处
《中国药师》
CAS
2022年第3期479-483,共5页
China Pharmacist
关键词
蛛网膜下腔出血
出血风险
抗栓治疗
药学监护
Subarachnoid hemorrhage
Bleeding risk
Antithrombotic therapy
Pharmaceutical care
